Melanoma antigen preferentially expressed in tumors (142-151)
  1. Home
  2. Peptides
  3. Others
  4. Melanoma antigen preferentially expressed in tumors (142-151)
Need Assistance?
  • US & Canada:
    +
  • UK: +

Melanoma antigen preferentially expressed in tumors (142-151)

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Melanoma antigen preferentially expressed in tumors (142-151) is a bioactive peptide of Melanoma antigen preferentially expressed in tumors. Melanoma antigen preferentially expressed in tumors inhibits the signaling of retinoic acid through the retinoic acid receptors RARA, RARB and RARG as a transcriptional repressor.

Category
Others
Catalog number
BAT-009678
Synonyms
Opa-interacting protein 4 (142-151); Preferentially expressed antigen of melanoma (142-151)
Sequence
SLYSFPEPEA
Storage
Common storage 2-8°C, long time storage -20°C.
Related Products
Boc-Gly-Gly-Phe-Gly-OH
Boc-Gly-Gly-Phe-Gly-OH

CAT NO. : BAT-009192
CYT-1010
CYT-1010

CAT NO. : BAT-006236
iRGD peptide
iRGD peptide

CAT NO. : BAT-006242
Boc-His(Trt)-Aib-OH
Boc-His(Trt)-Aib-OH

CAT NO. : BAT-000828
Larazotide acetate
Larazotide acetate

CAT NO. : BAT-006238
Neuropeptide Y (29-64)
Neuropeptide Y (29-64)

CAT NO. : BAT-009963
Online Inquiry
Verification code
Inquiry Basket
Loading ......
Delete selectedGo to checkout